Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Amy Franks to Clinical Trials as Topic

This is a "connection" page, showing publications Amy Franks has written about Clinical Trials as Topic.

 
Connection Strength
  
 
 
0.242
  
  1. Warmack TS, Estes MA, Heldenbrand S, Franks AM. Beta-adrenergic antagonists in hypertension: a review of the evidence. Ann Pharmacother. 2009 Dec; 43(12):2031-43.
    View in: PubMed
    Score: 0.073
  2. Muldrew KM, Franks AM. Succinobucol: review of the metabolic, antiplatelet and cardiovascular effects. Expert Opin Investig Drugs. 2009 Apr; 18(4):531-9.
    View in: PubMed
    Score: 0.069
  3. Franks AM, Gardner SF. AGI-1067: a novel vascular protectant for prevention of restenosis. Ann Pharmacother. 2006 Jan; 40(1):66-73.
    View in: PubMed
    Score: 0.055
  4. Gardner SF, Franks AM. Olmesartan medoxomil: the seventh angiotensin receptor antagonist. Ann Pharmacother. 2003 Jan; 37(1):99-105.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.